Page last updated: 2024-09-04

15-hydroxyeicosatrienoic acid and Chronic Illness

15-hydroxyeicosatrienoic acid has been researched along with Chronic Illness in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fadok, VA; Huynh, ML; Kotaru, C; Malcolm, KC; Tilstra, JA; Wenzel, SE; Westcott, JY1

Other Studies

1 other study(ies) available for 15-hydroxyeicosatrienoic acid and Chronic Illness

ArticleYear
Defective apoptotic cell phagocytosis attenuates prostaglandin E2 and 15-hydroxyeicosatetraenoic acid in severe asthma alveolar macrophages.
    American journal of respiratory and critical care medicine, 2005, Oct-15, Volume: 172, Issue:8

    Topics: Adult; Analysis of Variance; Anti-Inflammatory Agents; Apoptosis; Asthma; Bronchoalveolar Lavage Fluid; Case-Control Studies; Cell Survival; Chronic Disease; Dexamethasone; Dinoprostone; Female; Forced Expiratory Volume; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Hydroxyeicosatetraenoic Acids; Inflammation; Jurkat Cells; Macrophages, Alveolar; Male; Phagocytosis; Severity of Illness Index; Tumor Necrosis Factor-alpha; Vital Capacity

2005